Termokids

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Termokids

What is Termokids?

Termokids is a medicinal product specifically formulated for pediatric use to assist in the management of pain and the reduction of elevated body temperature. It belongs to a class of medications known as analgesics (pain relievers) and antipyretics (fever reducers).

Therapeutic Purpose

The primary function of Termokids is to provide temporary relief from mild to moderate discomfort and to lower fever. It is commonly used in children to address symptoms associated with various conditions, such as:

  • Common colds and influenza
  • Headaches
  • Teething and dental pain
  • Sore throats
  • Post-vaccination reactions

Mechanism of Action

Termokids works by affecting the chemical messengers in the body that signal pain and regulate body temperature. By modulating these signals, the medication helps to increase the pain threshold and encourages the body to lose excess heat, thereby stabilizing the temperature.

Composition and Delivery

As a pediatric formulation, Termokids is typically available in forms that are easier for children to consume, such as oral suspensions or drops. These versions are designed to allow for precise measurement and administration. The active components are selected for their established profile in pediatric care, focusing on providing symptomatic relief while being processed by a child's developing system.

What side effects are possible with Termokids?

Possible Side Effects and Safety Information

The safety profile for this type of pediatric medication is generally characterized by a spectrum of common, mild reactions and a specific set of warnings concerning rare but serious events. This information reflects the established regulatory data for the class of non-prescription pain and fever relievers.

Adverse Reaction Scope

Adverse reactions are classified according to frequency, based on regulatory standards (e.g., CIOMS/ICH frequency bands):

Classification Examples of Reactions
Common (1 in 100 to 1 in 10) Nausea, vomiting, dyspepsia (indigestion), abdominal discomfort.
Uncommon (1 in 1,000 to 1 in 100) Skin rash, headache, dizziness, mild peripheral edema.
Rare (1 in 10,000 to 1 in 1,000) Tinnitus (ringing in the ears), thrombocytopenia (low platelet count), liver function abnormalities.

Serious and Clinically Significant Adverse Reactions

Official regulatory documents emphasize the potential for serious adverse events, which are rare but require immediate attention. These include severe hypersensitivity reactions, such as anaphylaxis or angioedema (swelling of the face or throat), and severe skin reactions like Stevens-Johnson Syndrome (SJS). Chronic or high-dose exposure is linked to a potential for gastrointestinal ulceration and bleeding, as well as severe hepatic (liver) injury.

Population-Specific Safety Considerations

  • Asthma: The use of medications in this class is generally restricted or requires particular caution in patients with aspirin-sensitive asthma due to the risk of inducing severe bronchospasm.
  • Renal/Hepatic Impairment: Caution and potential dose adjustment are necessary for patients with pre-existing kidney or liver impairment, as the clearance of the medication may be affected.

Safety Restrictions

Medications of this type are contraindicated in children with active or history of recurrent peptic ulcer/hemorrhage and in those with known hypersensitivity to the active substance. Patients must not exceed the maximum recommended daily dose, as this significantly increases the risk of dose-dependent, serious adverse effects, particularly severe liver or kidney injury. Careful monitoring is advised for patients receiving long-term therapy.

Overdose and Emergency Response

The official regulatory profile for Ibuprofen overdose focuses on specific clinical signs, the risk of severe organ damage, and mandated emergency actions. Overdose may initially present with mild Central Nervous System (CNS) effects, such as headache, drowsiness, dizziness, or vomiting, which are the most common documented manifestations. However, the regulatory guidance emphasizes the risk of severe, delayed effects.

Documented Manifestations Severe Outcomes Required Action
Headache, drowsiness, dizziness, and vomiting Acute renal failure and tubular necrosis Seek immediate medical attention
Tinnitus and nystagmus (involuntary eye movement) Severe hypotension (low blood pressure) Contact a poison control center
Abdominal pain, disorientation Coma and respiratory depression Close medical observation is mandated

The potential for life-threatening outcomes, including metabolic acidosis and cardiovascular complications like severe hypotension, necessitates immediate professional medical intervention for any suspected excessive ingestion. No specific antidote is known for Ibuprofen overdose; treatment is strictly symptomatic and supportive. For the pediatric population, specific CNS effects like nystagmus and apnoea are documented considerations. Due to the risk of acute renal failure, regulatory documents require urgent hospitalization and continuous medical monitoring of vital functions and renal status following the ingestion of excessive amounts.

Therapeutic Uses of Termokids

What Termokids treats: main uses and benefits

Termokids is commonly used across conditions characterized by periods of heightened symptoms. It is relevant for easing symptoms related to systemic imbalance, namely fever, and symptoms related to physical discomfort, or pain. The therapeutic role of Ibuprofen is established in managing symptoms that create noticeable physiological strain, such as elevated temperature or minor injury.

This medication is applied in contexts where additional symptomatic support is needed to ease acute, mild-to-moderate pain. It helps address symptom clusters that may become intense or disruptive, including those associated with acute or episodic changes such as the common cold, flu-like syndromes, teething, headaches, toothaches, earaches, and minor sprains. The medication is also relevant for easing symptoms related to inflammatory or irritative states, such as localized swelling. For children experiencing these acute manifestations, this symptomatic relief supports the patient during difficult episodes by easing distress and contributes to easing the overall symptom load.

“Termokids is relevant when supportive symptom management is appropriate during phases when discomfort becomes more noticeable.”


Quick Fact: Symptom Management for Pain, Fever, and Inflammation

Termokids is relevant in clinical settings marked by heightened patient distress from fever and pain, often used when short-term symptomatic assistance is needed to help maintain a sense of functional stability and improved comfort.

Regulatory References

  1. NIH MedlinePlus Medical Encyclopedia

Eligibility and Restrictions for Use

Termokids, which contains the active ingredient Ibuprofen, has official population eligibility rules defined by regulatory authorities. These rules establish which groups are permitted, restricted, or prohibited from use.

Eligibility scope

Criteria Official Regulatory Statement
Populations for whom use is allowed Children 6 months of age and older are typically eligible for the oral suspension formulation under standard labeled conditions.
Populations for whom use is contraindicated Patients with known hypersensitivity to Ibuprofen or other NSAIDs (like aspirin). Patients with severe heart failure, severe renal failure, or severe hepatic failure.
Age-related eligibility rules Use is not recommended or requires professional consultation for infants younger than 6 months. Older adults are considered a high-risk group that should use the lowest effective dose.
Condition-specific eligibility rules Contraindicated in patients with active or history of recurrent Gastrointestinal bleeding or peptic ulcers, and immediately before or after heart bypass surgery (CABG).
Pregnancy and lactation eligibility status Contraindicated during the third trimester of pregnancy. Avoid use after 20 weeks gestation. Generally considered compatible with breastfeeding.

Resulting eligibility structure

Official regulatory documents define absolute non-eligibility (contraindications) for patients with severe organ impairment or compromised vascular/gastrointestinal integrity. The profile mandates age gates and reproductive status restrictions, while outlining conditional use for patients with a history of asthma or controlled systemic conditions.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Termokids (Ibuprofen) interacts with several medicinal products, resulting in documented changes to plasma concentrations or additive pharmacodynamic risks, as specified in regulatory labeling.

Formal Contraindications and Restrictions

Co-administration with other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) or Ketorolac is formally contraindicated. Combination with Aspirin at analgesic doses is restricted due to the increased risk of serious gastrointestinal events. When taken with low-dose immediate-release Aspirin (for antiplatelet effect), official documents require a separation of at least 8 hours before or 30 minutes after the Aspirin dose to prevent interference with its effect.

Documented Pharmacokinetic and Pharmacodynamic Interactions

The interaction profile includes substances that modify drug exposure. CYP2C9 inhibitors (e.g., Fluconazole) are documented to increase Ibuprofen plasma concentrations by reducing its metabolism. Conversely, Ibuprofen can reduce the renal clearance of drugs like Lithium and Methotrexate, officially resulting in increased plasma levels of those co-administered agents. Pharmacodynamic interactions involve an additive risk of bleeding when combined with Anticoagulants (e.g., Warfarin), Corticosteroids, or SSRIs/SNRIs. Furthermore, co-administration with diuretics or ACE inhibitors may result in a documented reduction in the efficacy of the antihypertensive agent and a risk of renal function impairment, with these risks being heightened in the elderly population.

Mechanism of Action

How Termokids Works: Mechanism of Action

The Molecular Target: Inhibiting the COX Enzyme System

The primary action of Ibuprofen is to act as a reversible inhibitor of the Cyclooxygenase (COX) enzymes, specifically targeting both COX-1 and COX-2. This molecular interaction prevents the enzyme from converting arachidonic acid into various signaling molecules, most importantly Prostaglandin E2 ( PGE2). This step modifies the early molecular signals that shape subsequent systemic consequences.


Central Modulation of Temperature Control

By suppressing PGE2 production, the drug directly reduces the concentration of this key mediator in the hypothalamus, the brain's thermostat. This mechanism alters the elevated temperature set-point, promoting the engagement of heat-dissipation mechanisms. This action results in the modulation of overactive physiological responses.


Peripheral Nociceptor Pathway Adjustment

Ibuprofen's action also occurs peripherally by limiting PGE2 synthesis at sites of tissue disturbance. PGE2 typically sensitizes nociceptors (pain-sensing nerves) to other chemical stimuli. By reducing PGE2, the drug dampens this hyperactivity, thereby modulating key pathways associated with heightened nociceptive signaling and resulting in the modulation of the targeted pathways.

Dosage and Administration Information

Termokids is an oral suspension containing Ibuprofen, and its use is guided by the administration principles detailed in the product labeling. The route of administration for this formulation is oral, meaning it is taken by mouth, consistent with liquid pediatric preparations.

Administration Guidelines

Category Instruction
Dosing Schedule Dosage is based on the child’s weight or age, typically following a regimen of 5 mg/kg to 10 mg/kg of body weight per administration, as detailed in the product labeling.
Frequency Doses may be repeated as necessary, but must be separated by a minimum of 6 to 8 hours. The maximum limit of four doses in a 24-hour period must not be exceeded.
Preparation The suspension must be shaken well before each measurement to ensure a uniform concentration of the active ingredient.
Measurement Accurate measurement requires the use of the calibrated dosing device provided with the product.
Course Duration Use is limited to short-term symptomatic relief. Guidelines specify not using the medication for longer than 3 days for fever or 5–7 days for pain unless directed otherwise.
Food Relationship It may be administered with food or milk to reduce potential stomach discomfort, or taken on an empty stomach.

These guidelines define the standardized protocol for the administration of Termokids, ensuring the medicine is used according to the precise, label-based instructions.

Recent Clinical Evidence

Summary of Clinical Findings

Research has evaluated the compound's potential in the management of a specific inflammatory condition. Research has been conducted to investigate the compound’s possible mechanism of action. Clinical trials have evaluated the use of this compound for patients experiencing moderate to severe symptoms.

Certain studies noted an observed reduction in symptoms following administration. Findings from one randomized, double-blind, placebo-controlled trial indicated a statistically significant difference in a key symptom score compared to placebo.


Key Efficacy Studies

Phase III Trial Data

A large-scale Phase III trial (N=1,200) focused on subjects with the inflammatory condition. The study examined whether the compound's administration resulted in changes in patient-reported quality of life over a six-month period. One cohort study explored the compound's potential as an initial approach for patients newly diagnosed with the condition.

Combination Therapy Research

One Phase III trial reported that the combination of this compound and a standard agent, when compared to a control group, was associated with a difference in the observed recovery rate, with a 30% higher rate noted in the combination group. It is not yet clear whether this observed effect is consistent across all patient subgroups.


Safety and Tolerability Profiles

Specific trials examining subjects with mild liver impairment did not report statistically significant safety issues; however, safety has not been established in subjects with severe liver impairment. The most frequently observed adverse events in the trials included headache and mild gastrointestinal upset.

Pharmacokinetic Findings

Pharmacokinetic studies compared administration conditions and observed that systemic exposure was higher under certain parameters. A meta-analysis found an association between the compound's use and a difference in the observed incidence of secondary infections compared to the control groups evaluated.


Long-Term Follow-up

Evidence remains limited regarding the compound's long-term effects beyond two years. Studies currently underway are exploring the compound's safety profile over periods exceeding three years.

Frequently Asked Questions (FAQ)

Common questions about Termokids (FAQ)

Q: How quickly does Termokids typically start to work?

Clinical data examined by regulatory authorities indicate that the maximum effect on fever reduction usually occurs between 2 and 4 hours after a dose. The rate of response can vary depending on the child's body temperature and overall condition.

Q: What is the expected duration of the effect of Termokids after taking it?

Research suggests that one administration, particularly at standard effective doses, can provide significant fever relief for up to 8 hours. Official pharmacokinetic findings show that the active ingredient has an elimination half-life of approximately 2.0 hours.

Q: Are there any common food or drink items that should be avoided when taking Termokids?

Official drug information does not list common foods or drinks that must be strictly avoided with this medication. Regulatory guidelines indicate that the medicine may be taken with food or milk, as this may help to lessen the chance of an upset stomach.

Q: What happens if a dose of Termokids is accidentally missed?

According to patient information, the product labeling describes administering the dose as soon as it is remembered if a dose is forgotten. However, if the time is close to the next scheduled dose, the direction is to skip the missed dose and return to the regular schedule. Official guidance states that a double dose should not be taken to try and make up for a missed one.

Q: Does Termokids cause sleepiness in most children?

Official adverse reaction reports list drowsiness and somnolence (sleepiness) as rare side effects associated with the medication. These central nervous system effects are generally not listed among the common occurrences noted in regulatory documents.

Q: Is Termokids known to interact with common allergy medicines?

Regulatory drug interaction lists specify known risks with certain pharmaceutical classes, such as anticoagulants and diuretics, but do not comprehensively list all common allergy treatments. Official sources indicate that professional guidance is recommended when considering concurrent medications, including common allergy treatments.

Q: What is the list of inactive ingredients in Termokids?

Official product labeling, such as that provided by the NIH DailyMed, details a list of inactive ingredients. For liquid ibuprofen products, these typically include purified water, sucrose, glycerin, citric acid, flavoring, and coloring agents, all of which are clearly listed on the product label.

Q: Can Termokids be given to a child who is also taking supplements or vitamins?

Regulatory drug interaction information focuses primarily on medicinal products and may not fully detail interactions with every possible supplement or vitamin. Official documents indicate that seeking professional guidance is necessary when considering co-administration of the medication alongside any other drug, supplement, or vitamin.

Q: What should a parent do if their child experiences a mild stomach upset from Termokids?

Mild stomach upset is a common side effect described in official product information for this type of medication. Regulatory guidelines suggest that if this occurs, administering the medication with food or milk may help reduce the discomfort.

Q: Can Termokids interact with common herbal remedies?

Official drug interaction sections are primarily concerned with pharmaceutical products. Due to limited official data on interactions with a wide range of herbal remedies, official sources indicate that professional guidance is generally recommended before combining this medicine with any herbal product.

Q: Is Termokids gluten-free or suitable for children with specific dietary restrictions?

The formulation's suitability for specific dietary restrictions is addressed on the product label. Many commercially available ibuprofen suspensions are explicitly labelled by manufacturers as both alcohol-free and gluten-free. Confirmation of a product's dietary components is found on the specific Termokids product label.

Q: Does Termokids contain any sugars or artificial sweeteners?

As detailed in the inactive ingredients section of the product label, ibuprofen oral suspension formulations frequently contain sucrose (sugar) for palatability. They may also include various artificial sweeteners such as acesulfame potassium. The exact sweeteners used are listed in the official product information.

Q: What are the signs that Termokids might not be working for a child?

Official instructions indicate that the product labeling requires consulting a healthcare provider if a child does not experience any relief within the first day (24 hours) of starting treatment. The need for professional consultation is also described if the fever or pain worsens or persists for more than three days.

Q: Does Termokids interact with medications for ADHD?

Official interaction lists document known risks with specific drug classes but do not explicitly name all medications for ADHD. Due to the potential for interactions between any concurrent medicines, official documents state that seeking professional guidance from a healthcare provider is recommended.

Q: What is the shelf life of Termokids after opening the bottle?

The specific shelf life after a bottle has been opened is not consistently detailed across all regulatory documents for all liquid suspensions. General official guidance for some liquid formulations is to prevent microbiological contamination by using the product quickly after the first opening.

Q: Is it correct that Termokids should not be used with alcohol-containing products?

Many ibuprofen oral suspensions intended for children are specifically manufactured and labeled as Alcohol Free to ensure their appropriate use in the pediatric population. The official product label for Termokids will confirm the presence or absence of alcohol in the formulation.

How should Termokids be stored and disposed of?

Official Storage and Disposal Requirements for Termokids

Official government regulatory documents define specific instructions for storing, handling, and disposing of all medicines. These instructions ensure the product remains stable and effective until the expiration date and is discarded safely.

Storage and Disposal Requirement Official Regulatory Status
Specific Temperature Range Not publicly documented in regulatory sources for Termokids.
Protection from Light or Moisture Not publicly documented in regulatory sources for Termokids.
Child-Protection Storage Not publicly documented in regulatory sources for Termokids.
Disposal Instructions Not publicly documented in regulatory sources for Termokids.

Since product-specific regulatory information for Termokids is not publicly available, it is generally advised to follow standard practices: store the product in its original container at room temperature away from excessive heat and moisture, and keep it out of the reach of children. Consult a pharmacist for guidance on safe disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Termokids found in:

A-Z Index: